Recent evidence suggests a coordinated regulation by the local renin-angiotensin system (RAS) and tissue kallikrein-kinin system (TKKS) of blood flow and substrate supply in oxidative red myofibres of skeletal muscle tissue during endurance exercise.The performance of these myofibres is dependent on the increased oxidation of substrates facilitated by augmenting nutritive blood flow and glucose uptake. Humoral factors released by the contracting fibres, such as adenosine and kinins, are suggested to be responsible for this metabolic adjustment.The considerable drain of blood volume and the enormous consumption of glucose during endurance exercise require a control mechanism for the maintenance of blood pressure (BP) and glucose homeostasis. This is achieved by the sympathetic nervous system and its subordinate RAS, which is located in the nutritive vessels and parenchyma of the red myofibres. The angiotensin-converting enzyme (ACE) is the primary enzyme responsible for kinin degradation during exercise, underscoring the important interrelationship between the RAS and the TKKS in the critical role of kinins in the multifactorial regulation of muscle bioenergetics and glucose and BP homeostasis. Importantly, overactivity of the ACE, as occurs in individuals displaying risk factors such as overweight, causes exaggerated BP response and reduced glucose disposal. If they persist over years, compensatory responses to this ACE overactivity, such as hypersecretion of insulin and compliance of the vessel walls, will inevitably be exhausted, leading ultimately to the manifestation of type 2 diabetes and hypertension. This concept also provides a unifying explanation for the beneficial effects of ACE-inhibitors and Angiotensin II receptor antagonists in the treatment of hypertension and insulin resistance.
delivered corresponding to the tissue's energy needs. During endurance exercise, muscle depends primarily on the availability of bloodborne substrates. Because the substrate delivery process is not controlled neurally, 1, 4, 5 the supply of oxygen, glucose, and free fatty acids (FFA) from the circulation is regulated locally by the contracting red myofibres themselves. 1, 3 This local regulation requires an exquisite paracrine signalling process involving the contracting red myofibres and the endothelial tissue of their nutritive vessels, which causes vasodilation of these vessels and thus induces accelerated blood flow when energy needs increase. 1, 6, 7 Additionally, the efficiency of energy metabolism is improved by accelerated glucose utilisation via an insulinindependent autocrine and paracrine signalling process, which induces translocation in the myocyte of the regulatable glucose transporter isoform glucose transporter isoform-4 (GLUT4) from an intracellular pool to the cell surface. 8 If a large organ such as SMT, which possesses the most substantial vascular network in the organism 1, 3, 5 and is a major site of whole-body glucose disposal, 9 begins to perform endurance work (i.e., a prolonged bout of running or cycling), compensatory control mechanisms are required in order to maintain blood pressure (BP) control and glucose homeostasis. Control mechanisms are necessary on the one hand for the adjustments of the cardiac output and the vascular diameter in other tissues such as kidneys, splanchnic region, but also in SMT itself, 1, 7, 10 and on the other hand for adjustments of hepatic glucose production and for glucose disposal in non-muscle tissues 9, [11] [12] [13] and skeletal muscle itself. The concept is summarised in figures 1 and 2.
During exercise, the enlargement of the precapillary and capillary regions with concomitant ascending upstream dilation in the vascular tree can be tremendous 7 -in man muscle blood flow can increase from a calculated basal value of about 1 L/minute up to about 20 L/min, representing about 80% of the cardiac output, as calculated by Golenhofen 5 by the method of Lassen. 14 comprise up to about 80% of the hepatic glucose output. 12 The significance of hepatic gluconeogenesis within this multifactorial glucose control system during prolonged exercise has been discussed in detail by others. 10, 12, 15, 16 The need for such control mechanisms is particularly convincing if one takes into account that there are physiologic limitations for the heart and the liver to provide tissues with either blood or glucose, respectively, during endurance exercise. 5, 12 Furthermore, in contrast to rodents, in humans oxidative red fibres account for about 70% of the muscle mass, 17, 18 and therefore may be regarded as the biggest tissue with the largest vascular network in the organism.
Control by the neuro-endocrine sympathetic nervous system and the renin-angiotensin system
During endurance exercise, the adjustments of the circulation and metabolism in the organism are predominantly controlled by the neuroendocrine sympathetic nervous system (NESNS) (figure 1). 1, 10 The SNS increases cardiac output, narrows the vascular diameter in tissues such as kidneys, gut, and skeletal muscle itself, accelerates hepatic glucose production by glycogenolysis and gluconeogenesis (via increased glucagon and reduced insulin secretion) as well as by augmented rates of lipolysis and ketogenesis, and limits glucose disposal in non-contracting tissues. 10, 15, 16 At the cellular level, glucose oxidation is replaced by the oxidation of FFA and ketone bodies in the various tissues (figure 1 and 2) and in SMT itself. [10] [11] [12] [13] [19] [20] [21] Glucose carbons return to the liver in form of lactate and alanine as substrates for gluconeogenesis (Cori-cycle). 10, 12, 15, 16 Glucose derived from SNS-accelerated hepatic glycogenolysis plays an important role for the maintainance of glucose homeostasis only during the first few minutes after onset of exercise.
In addition, the SNS has also direct influences in SMT. It has a powerful constrictive action in the proximal (PRV) and distal resistance vessels (DRV), opposing the ascending upstream dilation observed during contraction, 7 thereby directly contributing to the maintainance of overall BP. Its action is rather weak in the regions of the pre-capillary (PV) and capillary vessels (CV), 1, 5, 10 which play a profound role in the control of micro-vascular flow 22, 23 and of the capillary surface area which determines the uptake of substrates such as FFA. 12, 13 
Figure 1
Control of BP homeostasis during endurance exercise. At the onset of endurance exercise, there is simultaneous activation of the motoric ChNS and the NESNS. The ChNS recruits specifically the oxidative fast-and slow-twitch red fibres. The increased energy requirements elicit capillary vasodilation and ascending vasodilation in the larger PRV and the DRV. The resulting increase in SMBF can amount to 80% of cardiac output with loss of the circulating blood volume. The latter is compensated by NESNS activation to maintain mean arterial BP. The action of the NESNS constricts the larger PRV and DRV, counteracting the ascending vasodilation, whereas the RAS inhibits capillary and ascending vasodilation. The RAS also causes an increase in the plasma volume by facilitating the reabsorption of sodium and water in the kidneys and by increased release of norepinephrine from the sympathetic nerve endings, thereby potentiating the influence of the NESNS. ALD = aldosterone; BP = blood pressure; CBF = cerebral blood flow; ChNS = cholinergic nervous system; DRV = distal resistance vessels; NESNS = neuroendocrine sympathetic nervous system; PRV = proximal resistance vessels; RAS = renin-angiotensin system; RBF = renal blood flow; SBF = splanchnic blood flow; SMBF = skeletal muscle blood flow.
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Although the SNS-stimulated increase in the supply of FFA and ketones replaces glucose as a substrate for oxidation and contributes to the maintainance of glucose homeostasis, it does not affect the insulin-independent, contractioninduced acceleration of glucose uptake by the working red fibres, making this glucose-sparing mechanism essential. 19, [24] [25] [26] Therefore, these mechanisms would be otherwise insufficient to maintain glucose homeostasis if the SNS did not have an indirect restrictive influence via the renin-angiotensin system (RAS) on the PV and CV, and in particular on glucose uptake by the working red fibres (figure 1 and 2). 26 The RAS is activated by the SNS-induced release of the enzyme renin from the juxtaglomerular cells in the kidneys. It should be noted that this neural mechanism is only one of several mediators of renin release. The renin stimulates the conversion of angiotensinogen to angiotensin I (Ang I) in the endothelial tissue of the nutritive vessels and in SMT itself (figure 3). 26 Ang I is converted to Ang II by the peptidyl dipeptidase angiotensin-converting enzyme (ACE), which acts predominantly in the endothelium of the PV and CV and in the sarcolemma of the red myofibres ( figure 3 ), and to lesser degree in the DRV and PRV. 22, 26 This enzyme is also controlled by the SNS via cAMP. [27] [28] [29] The significance of this regulation in the red fibres is underlined by a two-three-times greater β-receptor density in red versus white muscle. 30 Ang II causes vasoconstriction and thus reduction of the microvascular bloodflow and antagonises the insulin-independent, contraction-induced glucose uptake in the working SMT. [31] [32] [33] This action is achieved via the Ang II type 1 (AT 1 ) receptor at the endothelium of the precapillary and capillary vessels and at the sarcolemma of the red myofibres. 26 The chronic effects of Ang II in myocytes are associated with a reduced protein expression of GLUT4, 33 suggesting limited availability of the glucose transporter to be at least partly responsible for the restricted glucose uptake. The facilitated release of local norepinephrine by prejunctional receptors could also modulate RAS activity. 34, 35 How much of the Ang II can reach its receptor sites is determined by the activity of ACE and Ang II-degrading endo-and amino-peptidases. 36 As a result of the distribution of ACE and AT 1receptors, Ang II action is greatest in PV and CV. 37 Control of blood glucose homeostasis during endurance exercise. The enhanced bioenergetic needs of the working muscle mass during endurance exercise cannot be met by the adjustment of skeletal muscle blood flow alone. Rates of glucose transport and utilisation are markedly enhanced during endurance exercise, consuming about 80% of the HGP. HGP is increased by activation of the NESNS, which enhances also glucagon and inhibits insulin secretion. In addition, it increases rates of lipolysis in adipose tissue, accelerates rates of ketogenesis in the liver, and FFA and ketone bodies replace glucose as a substrate for oxidation in every tissue. It is released by the tissues as lactate and alanine which serve as substrates for enhanced hepatic gluconeogenesis. However, all these compensatory mechanisms would not be sufficient to maintain blood glucose homeostasis if the NESNS would not restrict glucose transport into skeletal muscle tissue via activation of its subordinate RAS by stimulation of renin release from the kidneys. FFA = free fatty acids; HGP = hepatic glucose production; NSNS = neuroendocrine sympathetic nervous system; RAS = renin-angiotensin system.
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AT 2 -receptors appear to play a minor role in adult humans. 38 The Ang I analog Ang (1-7) 39 facilitates vasodilation and substrate delivery involving synthesis and release of prostaglandins and nitric oxide (NO), but its physiological role remains elusive. 40 In addition to its action in SMT, increased plasma renin stimulates the release of antidiuretic hormone from the anterior pituitary gland and aldosterone from the adrenal glands during endurance exercise, thus increasing circulatory volume by accelerated renal reabsorption of sodium and water (figure 1). 41
Adjustments of skeletal muscle energy provision by autocrine and paracrine mechanisms
The expansion of the PV and CV (with an accelerated inflow of blood) is accompanied by a dilatation of the conductance vessels upstream. This mechanism is thought to be mediated by the endothelial release of vasodilators induced by shear stress 7 and other factors, such as the endothelial-derived hyperpolarising factor (EDHF). 7 This so-called "antidromic vasodilation" appears indispensable for the maintenance of adequate nutritive blood flow in working SMT and is thought to be involved in the rapid onset of functional hyperaemia. 7 However, the local mechanisms that enable the working red fibres to increase the diameters of their nutritive vessels, to achieve the antidromic vasodilation, and to accelerate their insulin-independent glucose metabolism, still remain to be defined. 7, [42] [43] [44] In 1961, Goldstein 42 was one of the first to suggest that a humoral factor must be involved, which is released by the working tissue and mediates the adjustment of its bioenergetic state. A few years later, Mellander and Johansson 45 discussed the properties required of any such vasodilatory substance and concluded that metabolic requirements and blood flow are linked by metabolic signals. Adenosine and kinins have long been considered to be candidates for such a locally-produced humoral factor, 1,46-52 although their importance has been challenged. [53] [54] [55] [56] Both adenosine and kinins fulfil most of the criteria as postulated. 45 They are naturally-occurring, their levels can increase in the interstitial fluid, 57, 58 and they are released from SMT during contractions. 46, [59] [60] [61] When provided intra-arterially to achieve physiologically relevant concentrations, they accelerate muscle blood flow, mediating vasodilation primarily in the PV and CV, as is observed during contractions. [62] [63] [64] [65] [66] Moreover, they increase glucose utilisation in SMT similar to a contraction stimulus. [48] [49] [50] Thus, both adenosine and kinins may contribute to the multifactorial metabolic control of the physiological responses of SMT during endurance exercise. 58 However, with regard to their physiological role in this multifactorial regulation, kinins appear to fit better into the inherent mechanisms which optimally control muscle bioenergetics and thus maintain BP and glucose homeostasis during endurance exercise, as will be discussed in the following section. 
Figure 3
Molecular mechanisms of action of the RAS in skeletal muscle tissue during exercise. During endurance exercise, renin release from the kidneys is stimulated by the NESNS. Direct actions and ultimate vascular and metabolic consequences of the NESNS are shown in red. Renin levels increase in the plasma and interstitial fluid and convert angiotensinogen to Ang I. Ang I is transformed to Ang II by ACE in the endothelial tissue of precapillary and capillary vessels (eACE) and at the sarcolemma of the oxidative red myofibres (mACE). Ang II, acting through the AT 1 -receptor in endothelial and muscle tissue, decreases capillary and ascending vasodilation and inhibits glucose transport in the red myofibre. ACE = angiotensin-converting enzyme; Ang = angiotensin; AT 1 = Angiotensin II type 1; eACE = angiotensin-converting enzyme in endothelial tissue; mACE = angiotensin-converting enzyme in muscle tissue; NESNS = neuroendocrine sympathetic nervous system; RAS = renin-angiotensin system.
central role of ACE in control of skeletal muscle energy provision, BP, and glucose homeostasis
In a seminal study, Yang et al. 67 reported thirtyfive years ago that ACE not only catalyzes the conversion of Ang I to Ang II (which causes vasoconstriction and inhibits glucose metabolism), but also is the primary enzyme, in addition to less significant endopeptidases, aminopeptidases and carboxypeptidases, responsible for the degradation of kinins (which mediate vasodilation and improve glucose uptake; [figure 4]). In addition to the generation of Ang II, which antagonises increased muscle blood flow and glucose uptake, these actions of kinins are further restricted by their simultaneous degradation, an effective biochemical mechanism that emphasises the requirement for strict control of metabolic adjustments in SMT. This concept is underlined by the fact that rate of kinin degradation exceeds the generation of Ang II. 68 In this context, it is clear that the level of ACE activity is crucial for the optimal regulation of muscle bioenergetics and the maintainance of BP and glucose homeostasis. During endurance exercise, when ACE activity is inhibited and the degradation of kinins and generation of Ang II are decreased secondary to a drop in pH 69 and cellular cAMP [27] [28] [29] and by the rise of cytosolic Ca 2+70 and interstitial adenosine, 71 the metabolic influence of the working red fibres will increase according to their energy needs. These changes will enlarge the vascular network and enhance glucose utilisation ( figure 3) . In order to maintain BP control and glucose homeostasis during endurance exercise, the SNS in turn further enhances ACE activity, thereby antagonising the contracting muscle's ability to inhibit ACE and leading to increased kinin degradation and Ang II generation and to a limitation of the enlargement of the vast vascular network and of the enormous glucose consumption in the working muscle mass ( figure 4 ).
There is a clear and important interrelationship between the RAS and the TKKS in the multifactorial regulation of muscle bioenergetics and glucose and BP homeostasis, and it is critical at this stage to discuss the specific role of kinins in this regulatory scheme, as follows. Figure 4 summarises the current evidence in the literature that supports the roles of kinins and the RAS in bioenergetic adjustments of red myofibres. It should be stressed that all of the necessary components of the kinin system, including the precursor proteins, the enzyme that generates kinins, and the B 2 kinin receptors, are present in the endothelium of the nutritive vessels and in the red fibres of SMT. 26, 54, [72] [73] [74] [75] Vasodilation of these nutritive vessels in red muscle is completely endothelium-dependent, in contrast to the nutritive vessels of white muscle. 76 It is of interest to note that kinins display their vasodilating and metabolic actions not only in an endothelium-dependent manner, 63, 64, [76] [77] [78] but also when applied interstitially. 79 Kinins are involved in the effects of contraction and insulin on vasodilation and glucose transport, respectively, primarily in muscles containing predominantly red fibres. 47, 49, [80] [81] [82] [83] Inhibiting kinin generation attenuates their actions, 48, 50 whereas blocking their degradation has the opposite effect. [84] [85] [86] [87] [88] The provision of kinins accelerates GLUT4 translocation to the sarcolemma and increases glucose transport activity by an insulin-, protein kinase C-, and phosphatidyl-inositol-3kinase-independent pathway. 81, 82 The action of kinins on glucose transport is linked in part to Ca 2+ -influx across the sarcolemma and in part to Ca 2+ -release from intracellular stores (figure 4). 78 This mechanism mimics contraction-dependent glucose transport activity in the slow-twitch red fibre, which is a Ca 2+ -dependent process. 88 Kinins mediate their actions via their B 2 -receptors primarily at the endothelium of their nutritive vessels, 73 but also at the sarcolemma of the myocytes, 26, 74 which couple mainly to the Gq subfamily of heterotrimeric G-proteins. 89 The actions of kinins can be abolished by specific antagonists of their B 2 -receptors. 84, 90 Via B 2receptor-dependent mechanisms kinins activate enzymes such as nitric oxide synthase (NOS), cyclooxygenase (COX), and cytochrome P450-2C9monooxygenase (P450-2C9) in the endothelial tissue and in SMT itself (figure 4). 78 The activation of these enzymes is due to the actions of kinins on Ca 2+ release from intracellular stores via inositol-1-4-5-trisphosphate 74 and on prolonged transmembraneous Ca 2+ influx. 78 These enzymes also generate transmitter molecules such as nitric oxide (NO), prostaglandins (PGE 2 and PGI 2 ), and EDHF, which exhibit vasodilatory and glucose metabolism-promoting actions. [91] [92] [93] [94] [95] [96] [97] [98] These transmitters also play a role in the adjustments of energy metabolism to muscle contractions ( figure 4 ). [99] [100] [101] [102] [103] [104] [105] Because the effects of kinins are attenuated by inhibitors of the three enzymes mentioned above, causing diminished concentrations of downstream factors, [106] [107] [108] [109] [110] it has been postulated that kinins signal through NO, prostaglandins, and EDHF. 78 The molecular mode of action of these mediators has been described in detail by others. 78, 111 NO has been shown to mediate exercise-stimulated glucose transport by GLUT4 translocation independent of insulin and phosphatidylinositol-3kinase, as is the case with kinins, 81 and this effect is blocked by the NOS inhibitor L-NMMA. [112] [113] [114] Moreover, NO stimulates glucose transport by increasing the activity of the alpha-1-catalytic subunit of 5´-AMP-activated protein kinase (AMPK), a signalling molecule implicated in mediating glucose transport in energy-depleted cells. 115, 116 NO derived from kinin stimulation has been suggested to be involved also in insulin action. 83, [117] [118] [119] Lastly, from an anatomical perspective, it is appropriate that the intracellular signalling pathways required to generate and respond to NO are present only in vessels associated with highly oxidative muscle fibres, and NO-dependent vasodilation is therefore more prominent in highly oxidative muscle groups. 76, 120 Prostaglandins, such as PGE 2 and PGI 2 , may also participate in the control of vasodilation in SMT. 7, 102, 103, 105 Prostaglandins are formed and released during contractions in the venous effluent. Their concentrations increase in the intercellular space, and they contribute to contraction-induced vasodilation in humans. 99, 103, 105, 121, 122 In eNOSdeficient knockout mice, prostaglandins may compensate for the lost vasodilatory potential of the vasculature. 123, 124 A limited number of investigations in the last 30 years have focused on the effects of prostaglandins on glucose metabolism in SMT, in some cases with conflicting results. In isolated soleus muscle, prostaglandins of the E-series increased the insulin sensitivity and rates of glycolysis. 125 This finding was supported by studies showing significant increases of insulinstimulated glucose transport activity in rat skeletal muscle by prostaglandins. 126, 127 However, in the perfused rat hindlimb model, prostaglandins have not been found to mediate changes in glucose uptake, despite the finding that insulin can stimulate prostaglandin release. 128 Results obtained in the human forearm support the potential influence of prostaglandins on insulin-stimulated glucose uptake in SMT. 129 This contention is also supported by a study indicating that prostaglandins are involved in the insulin-mediated generation of an activator of pyruvate dehydrogenase. 130 The possible involvement of kinins and prostaglandins in insulin action in the face of an altered energy state in SMT has been discussed previously. 131 To date, only three naturally-occurring molecules acetylcholine, kinins and substance P, have been found to cause endothelium-dependent, NO-/ PGI 2 -independent vasodilation in resistance vessels and in microvessels. 97, 98, 109, 132 They increase intracellular free Ca 2+ concentration via their endothelial receptors and thus activate Ca 2+activated K + channels, which hyperpolarise endothelial cells. The accumulating K + in the intercellular space activates inwardly rectifying K + channels and Na + -K + -ATPase. Therefore, K + is currently viewed as a contributor to the mechanism of EDHF-mediated responses. 132 Electrical coupling through myo-endothelial gap junctions is required and may explain the phenomenon of ascending vasodilation (i.e. vasodilation in the conductance vessels) that occurs during muscle contraction. 133, 134 In the human forearm microvasculature, EDHF appears to be a cytochrome P450-derivative, possibly an epoxyeicosatrienoic acid. 109, 134 Importantly, P450-2C9 has been found in the endothelial cells of the microvessels in human SMT. 7 EDHF may be involved in exercise hyperaemia, as kinin generation and release and ascending vasodilation occur simultaneously during contractions. 7 This view is supported by the finding that combined inhibition of P450-2C9 and NOS reduces exercise-induced blood flow in the human forearm. 135 Under physiological conditions at normal pH, the production of EDHF is generally attenuated by NO. 136 A role for EDHF during contractions is also supported by the observation that the NO generation declines with a decrease in pH, and EDHF subsumes the role of NO. 78, 137 EDHF also assumes the same role in endothelial NO synthase (eNOS) knock-out mice, mediating flow-induced vasodilation of arterioles in SMT. 138 Lastly, it is of interest that kinins have Table 1 Contribution of the disrupted skeletal muscle ACE to the etiology of type 2 diabetes, hypertension and atherosclerosis Key: ACE = angiotensin-converting-enzyme; ADH = antidiuretic hormone; Na+ = NESNS = neuroendocrine sympathetic nervous system; SMC = smooth muscle cell. also been reported to be involved in flowdependent vasodilation of resistance arteries in kallikrein-and B 2 -receptor knock-out mice. 139 Recent results showing EDHF as an important modulator of vascular tone in eNOS/COX 1 -double knock-out mice suggest that EDHF may play a significant physiological role in the regulation of BP. 140 This concept is underlined by the finding that EDHF mediates relaxation of vascular smooth muscle cells (SMC) in hypertension. 141 At the conclusion of this section it must be emphasised once more that kinins, in the intact organism, diminish the influence of the neuroendocrine sympathetic nervous system (NESNS) on the vascular SMC and on glucose metabolism in the contracting high-oxidative red fibres. 34, 35, 142, 143 Possible role for endothelial and skeletal muscle tissue ACE in the development of type 2 diabetes, hypertension, and atherosclerosis Risk factors for the development of atherosclerosis, including male gender, aging, ACE-D-allele, stress, central obesity, smoking, hypertension, type 2 diabetes, and dyslipidaemia, are associated with various degrees of endothelial dysfunction (summarised in table 1). 117, [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] This dysfunction appears to be linked to an accelerated rate of ACE activity in the endothelial tissue of the whole vascular system, leading to increased generation of Ang II and enhanced degradation of kinins, and these observations support the concept that ACE overactivity plays a major role in the development of the atherosclerotic process in the vessel wall. 150 This scenario is also seen in the vast vasculature of SMT and its huge parenchyma, with an accelerated degradation of kinins by reduced release of these peptides from the working tissue. 155, 156 As SMT has twenty times more mass than all tissues combined and possesses the largest vascular network, dysfunctions in this tissue will negatively impact not only the regulation of adequate energy supply in the working tissue itself, [157] [158] [159] but will also compromise the control of BP and glucose homeostasis in the whole organism. It is therefore not surprising that a disruption of ACE activity by these risk factors is accompanied by an exaggerated BP response during a workload 160 and by impaired insulin sensitivity in the face of a glucose challenge 161, 162 (table 1) . It must also be mentioned that negative sequelae in non-SMT tissues listed in table 1 (heart, kidney, brain, adrenals and the NESNS) will contribute to this exaggerated BP response with stress by increasing the circulatory volume. 41 If one or more of these ACE-activating risk factors and the associated endothelial dysfunction persist over a period of years, 154 it may ultimately exhaust any compensatory control mechanisms responsible for the maintenance of BP and glucose homeostasis. In the case of glucose homeostasis, this will lead to a loss of the compensatory hypersecretion of insulin, due to a relative pancreatic β-cell dysfunction (table 1) , 163 with a concomitant loss of insulin-mediated glucose disposal. In the case of BP homeostasis, compensatory compliance of the vessel wall will be lost due to continuously increasing vascular stiffness (table 1) . 164 Reduction or elimination of these risk factors, such as overweight, smoking, type 2 diabetes, hypercholesterolaemia, and hypertension, by lifestyle changes or with medication have been found to improve or normalise endothelial dysfunction and its consequences. [165] [166] [167] [168] [169] Correction of the risk factor-induced imbalance of the ACE activity has been achieved by the use of specific inhibitors of the enzyme (ACEinhibitors), which not only attenuate endothelial dysfunction and thus improve glucose metabolism in states of insulin resistance, [84] [85] [86] but importantly also reduce the incidence of type 2 diabetes. 151, [170] [171] [172] The relevance of the reduced generation of Ang II for the protective action of ACE-inhibitors can be seen from studies showing that Ang II receptor antagonists exhibit almost the same effects as those elicited by ACE inhibitors. 170 The generation of kinins is equally important in this context, as studies indicate that B 2 -receptor antagonism worsens hypertension and insulin resistance in human 173, 174 and in kinin B 2 -receptor knock-out mice [175] [176] [177] and kininogen-deficient rats. 178 Moreover, amelioration of hypertension and insulin resistance has been achieved in rodents by specific overexpression of the kinin B 2 -receptor gene and the kallikrein gene. 177, 179, 180 Further insight into the mechanisms of relative overactivity of the RAS comes from investigations using the TG(mREN2)27 rat, which harbours the mouse REN2 transgene 181 and displays local elevations of the RAS. [181] [182] [183] The TG(mREN2)27 rat is characterised by markedly elevated systolic BP [181] [182] [183] [184] [185] and whole body as well as skeletal muscle insulin resistance. [183] [184] [185] A specific role of Ang II in the etiology of the insulin-resistant state is supported by the fact that whole-body insulin sensitivity and insulin action on skeletal muscle glucose transport are enhanced following chronic treatment of TG(mREN2)27 rats with an AT 1 -selective receptor antagonist. 183, 185 In addition, treatment of other insulin-resistant rat models, such as the obese Zucker rat, with either ACEinhibitors, 84, 186, 187 or an AT 1 -selective receptor antagonist 33 enhances whole-body and skeletal muscle insulin sensitivity and is associated with increased expression of the GLUT4 glucose transporter isoform in skeletal muscle. 
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Conclusions
A common root for insulin resistance, hypertension, and atherosclerosis has been postulated previously. [188] [189] [190] [191] Based on the evidence presented in this review, we propose a new concept for the pathophysiology of type 2 diabetes, hypertension and atherosclerosis. Like a sentinel, ACE in the vast vasculature and the huge mass of SMT on the one hand secures blood flow and energy support for the working red muscle fibres, and on the other hand guarantees BP and glucose homeostasis for the organism as a whole. Until now it was assumed that the disruption of the homeostatic balance of ACE activity in the arterial vessel wall of the vasculature in the whole organism due to risk factors, such as obesity, plays the leading role in the onset and progression of atherosclerosis (table 1) . 150 However, this ACE overactivity also occurs in the vast vasculature and huge mass of SMT and is associated with local metabolic dysregulation, which, via a negative impact on BP control and glucose homeostasis and subsequent development of type 2 diabetes and hypertension, will also contribute to the progression of this deleterious vascular disease (table 1) . It should be noted, however, that in clinical studies the pharmacological inhibition of ACE under normal conditions or under conditions characterised by cardiovascular and metabolic dysfunctions does not deleteriously affect normal organ functions.
Perspectives
While there is considerable evidence supporting the concept that kinins exhibit their actions using a paracrine action of signalling -binding to their B 2 -receptors in the endothelium of vessels and eliciting locally the generation of second messengers such as NO, prostaglandins (PGI 2 and PGE 2 ), and EDHF 78,93-123 -little information is available regarding their potential additional actions via autocrine signalling after binding to their B 2 -receptors on the sarcolemma of the muscle fibres. [73] [74] [75] 89 It is clear that further studies are needed to elucidate the molecular actions of kinins at their target cells. Furthermore, the functional significance of these new aspects in the kinin signalling cascade, reported recently by Erdös and coworkers, [192] [193] [194] [195] are also functional in SMT and contribute to the overall improvement of muscle bioenergetics and glucose metabolism mediated by ACE-inhibitors. This concerns not only the activation of the B 2 -receptor by kallikrein without kinin release, 192, 193 but also the fact that Ang 1-7 via its own receptors and Ang 1-9 can antagonise Ang II and thus may potentiate kinin action on the B 2 -receptor. 194, 195 It is of further interest to elucidate the role of local renin receptors in SMT. These renin receptors have been found in other tissues to be localised in the cellular membrane and to promote Ang II release. 196, 197 Prorenin has also been found to be activated in the cellular membrane without cleavage of the propeptide.
Finally, one is tempted to speculate that interactions between the RAS and the TKKS may also be crucial for the adjustment of the oxidative energy metabolism in other tissues. This idea is supported by studies in myocardial tissue demonstrating that oxidative metabolism and myocardial performance is dependent on a balanced ACE activity. 75, 198 Further investigations in this area are clearly required to more thoroughly evaluate this concept. 
